FDA accepts IND for the treatment of mucopolysaccharidosis type IIIA
The FDA has issued a Study may proceed letter for the first study in humans, thereby accepting the investigational new drug application for the drug candidate SOBI003...
List view / Grid view
News
Computational method provides a potential boon in fighting antibiotic resistance
A team of computer scientists have developed an algorithm that can rapidly search massive databases to discover novel variants of known antibiotics...
Robotic implant aids the treatment of oesophageal atresia
Engineers have created a robot that can be used to help treat babies with a rare birth defect that affects an infant's oesophagus...
Sanofi to acquire haemophilia specialists Bioverativ for $11.6bn
Sanofi and Bioverativ Inc., have entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Bioverativ...
EC approves first biosimilar Mvasi for the treatment of cancer
The European Commission has granted marketing authorisation for Mvasi for the treatment of certain types of cancer...
Fosmidomycin-piperaquine combination provides promising malaria treatment
An international research team has conducted successful phase II clinical tests of a new anti-malaria medication...
Prescription labels provide insufficient dosing guidance for obese children
Despite providing incentives to drug manufacturers to encourage the study of medications in children, few approved drugs include safe dosing information for obese children...
BM32 vaccine developed against rhinitis
Researchers have shown that the synthetically manufactured vaccine BM32 relieves the symptoms of rhinitis...
Ultra-thin optical fibers offer new way to 3D print microstructures
For the first time, researchers have shown that an optical fiber as thin as a human hair can be used to create microscopic structures with laser-based 3D printing.
Triclosan may help fight drug-resistant malaria
An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of the malaria parasite that have grown resistant to one of the currently used drugs...
Report calls into question effectiveness of pyridoxine-doxylamine
Previously unpublished information from the clinical trial that the FDA relied on to approve the most commonly prescribed medicine for nausea in pregnancy indicates the drug is not effective...
FDA approves new indication for Gilotrif in EGFR mutation-positive NSCLC
The FDA has approved a supplemental New Drug Application for Gilotrif for the first-line treatment of patients with metastatic non-small cell lung cancer...
GDM points toward heightened risk of heart disease
Women who have gestational diabetes mellitus during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future...
AI technology significantly improves human kidney analysis
The ability to quantify the extent of kidney damage and predict the life remaining in the kidney is now possible using a computer model based on artificial intelligence...
New study offers insights on genetic indicators of COPD risk
Researchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who are particularly at risk for COPD...
